MergerLinks Daily Review
MergerLinks
Join a community of 250,000+ M&A professionals. Expand your network and discover new business opportunities.
Welcome to MergerLinks Daily Review.?Sign up here?to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.
You can access today’s complete newsletter?here.
Scroll down for more…
Bayer plans to spend $1bn on US drug R&D in 2023.?
KKR, others in race for South Korean PE firm IMM's $1bn stake in AirFirst. (FS)
喜力 ’s purchase of South Africa’s biggest wine exporter got the final regulatory approval it needed, setting up the Dutch brewer for expansion across the continent.?
South Africa’s Competition Tribunal gave the deal with Distell the go-ahead with conditions. Shareholder elections are expected in two weeks and the transaction is expected to be implemented from April,?Bloomberg?reported.
Distell is advised by BDO (led by? Nick Lazanakis ). Heineken is advised by Nomura , De Brauw Blackstone Westbroek (led by? Jan Willem Hoevers ) and 爱德曼 (led by? Alex Simmons ). Remgro is advised by 汇丰 .?
Public Power, an electric power company, agreed to acquire Romanian operations business from Enel Group , a manufacturer and distributor of electricity and gas, for $1.33bn.
领英推荐
“With the sale of all our activities in Romania, we continue to implement the disposal plan that was announced during the presentation of Enel’s 2023-2025 Strategic Plan. We are proud of the results achieved in Romania since we entered the country in 2005 and we recognize the hard work and dedication of our colleagues, who enabled us to become one of Romania’s main integrated energy operators. We are confident that a leading international player such as PPC will continue this success story,"?Francesco Starace, Enel Group CEO and General Manager.
Informa , a publishing company, agreed to acquire Tarsus Group , a B2B events and media company, from Charterhouse Capital Partners , for $940m.
"We have long admired the Tarsus business which, like Informa, has been built around major brands in attractive, specialist B2B markets in the growing regions of Asia, China, the Middle East and the Americas," Stephen A. Carter, Informa CEO.
Informa is advised by Teneo (led by? Tim Burt ?and? Simon Duke ).
Bayer plans to spend $1bn on US drug R&D in 2023.?
Bayer plans to spend $1bn on drug research and development in the US this year as it works to double its sales in the country by the end of the decade, Bayer's top US pharmaceutical executive said,?Reuters?reported.
"The company had raised the number of US employees working on marketing for its pharmaceutical business by around 50% over the last three years, and plans to expand on that by another 75% by 2030," Sebastian Guth, Bayer President.?
KKR, others in race for South Korean PE firm IMM's $1bn stake in AirFirst. (FS)
South Korean’s IMM Private Equity has drawn interest from funds including KKR, MBK Partners and Brookfield Asset Management for a minority stake in local industrial gas company AirFirst which it aims to sell for $1bn.
The buyout firm is expecting first-round, non-binding bids by March 16.?IMM PE acquired the South Korean assets of German industrial gases group Linde for $1.2bn?in 2019 and rebranded the company as AirFirst,?DealStreetAsia?reported.
Interested to find more??Sign up here?to get full round up of your daily dose of blue-chip M&A news directly to your inbox.
You can access today’s complete newsletter?here.?